Worldwide Webb Acquisition (NASDAQ:WWAC) and Moolec Science (NASDAQ:MLEC) Head to Head Survey

Moolec Science (NASDAQ:MLEC) and Worldwide Webb Acquisition (NASDAQ:WWAC) are both small-cap consumer staples companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, dividends, risk, analyst recommendations, institutional ownership, valuation and earnings.

Profitability

This table compares Moolec Science and Worldwide Webb Acquisition’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Moolec Science	-129.97%	-97.95%	-27.91%
Worldwide Webb Acquisition	N/A	N/A	N/A

Analyst Ratings

This is a breakdown of current recommendations and price targets for Moolec Science and Worldwide Webb Acquisition, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Moolec Science	0	0	1	0	3.00
Worldwide Webb Acquisition	0	0	0	0	0.00

Moolec Science currently has a consensus price target of $6.00, suggesting a potential upside of 614.29%. Given Moolec Science’s stronger consensus rating and higher probable upside, analysts clearly believe Moolec Science is more favorable than Worldwide Webb Acquisition.

Insider and Institutional Ownership

0.1% of Moolec Science shares are owned by institutional investors. Comparatively, 49.1% of Worldwide Webb Acquisition shares are owned by institutional investors. 19.9% of Moolec Science shares are owned by insiders. Comparatively, 43.0% of Worldwide Webb Acquisition shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Earnings and Valuation

This table compares Moolec Science and Worldwide Webb Acquisition”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Moolec Science	$5.62 million	5.75	-$7.31 million	($0.20)	-4.20
Worldwide Webb Acquisition	N/A	N/A	N/A	N/A	N/A

Worldwide Webb Acquisition has lower revenue, but higher earnings than Moolec Science.

Risk & Volatility

Moolec Science has a beta of -0.47, suggesting that its stock price is 147% less volatile than the S&P 500. Comparatively, Worldwide Webb Acquisition has a beta of 0.07, suggesting that its stock price is 93% less volatile than the S&P 500.

Summary

Worldwide Webb Acquisition beats Moolec Science on 6 of the 10 factors compared between the two stocks.

About Moolec Science

Moolec Science SA, a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product. It operates in the United States, Europe, and South America. The company was founded in 2020 and is based in Luxembourg.

About Worldwide Webb Acquisition

Worldwide Webb Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to identify business opportunities in the field of direct-to-consumer brands, amazon-centric, online marketplace, food tech, new media, digital health, software-as-a-service, fintech, and others. The company was incorporated in 2021 and is based in Orem, Utah.